About Alembic Limited
Alembic Limited is a company based in Vadodara (India) founded in 1907. The company has 323 employees as of March 31, 2024. Alembic Limited operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Vadodara, India
- Employees 323 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Alembic Limited
-
Annual Revenue
$25.99 M (USD)40.97as on Mar 31, 2025
-
Net Profit
$36.4 M (USD)15.66as on Mar 31, 2025
-
EBITDA
$11.03 M (USD)65.17as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
323
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Alembic Limited
Alembic Limited is a publicly listed company on the NSE with ticker symbol ALEMBICLTD in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Alembic Limited
Investments & Acquisitions by Alembic Limited
Financial Statements - Alembic Limited
Alembic Limited Comparisons
Competitors of Alembic Limited
Alembic Limited operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Latest news on Alembic Limited
Frequently Asked Questions about Alembic Limited
Alembic Limited was founded in 1907.
Alembic Limited is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Malika C Amin is the current CEO of Alembic Limited.
As of Mar 31, 2024, the latest employee count at Alembic Limited is 323.
Annual revenue of Alembic Limited is $25.99M as on Mar 31, 2025.
Alembic was established in 1907 and is headquartered in Vadodara, India. Operations focus on the production of active pharmaceutical ingredients within the healthcare sector. The company maintains facilities for manufacturing these essential components used in drug formulations. Leadership is provided by Malika C Amin as CEO and Managing Director. Activities are centered in the pharmaceutical industry, supporting global supply chains from its Indian base.
Alembic Limited's top competitors include Merck, Roivant Sciences and AbbVie.
Yes, Alembic Limited is publicly traded on NSE under the ticker symbol ALEMBICLTD.
The ticker symbol of Alembic Limited is ALEMBICLTD on NSE.